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The complement system, which functions by lysing
pathogens directly or by promoting their uptake by
phagocytes, is critical for controlling many microbial
infections.Here,weshowthat inStreptococcuspneu-
moniae, increasing bacterial chain length sensitizes
this pathogen to complement deposition and subse-
quent uptake by human neutrophils. Consistent with
this, we show that minimizing chain length provides
wild-type bacteria with a competitive advantage
in vivo in a model of systemic infection. Investigating
how the host overcomes this virulence strategy, we
find that antibody promotes complement-dependent
opsonophagocytic killing of Streptococcus pneumo-
niae and lysis ofHaemophilus influenzae independent
of Fc-mediatedeffector functions.Consistentwith the
agglutinating effect of antibody, F(ab0)2 but not Fab
could promote this effect. Therefore, increasing path-
ogen size, whether by natural changes in cellular
morphology or via antibody-mediated agglutination,
promotes complement-dependent killing. These ob-
servations have broad implications for how cell size
and morphology can affect virulence among patho-
genic microbes.
INTRODUCTION
Streptococcus pneumoniae (the pneumococcus) is a leading
cause of invasive bacterial infection (O’Brien et al., 2009). This
pathogen was previously known as Diplococcus pneumoniae
because it is typically seen clinically in the form of diplococci
or short bacterial chains. This is in contrast to closely related
streptococci, however, which typically appear as long bacterial
chains. The underlying reason for this difference in bacterial
chain length between pneumococci and other streptococci,
however, has remained unclear.
Pneumococcal infections are controlled by host neutrophils,
which kill this pathogen via opsonophagocytosis (OPH), a pro-
cess that requires opsonization of bacteria by the complement
system (Dalia et al., 2010; Lysenko et al., 2007; Matthias et al.,486 Cell Host & Microbe 10, 486–496, November 17, 2011 ª2011 Els2008). Activation of this system results in the covalent deposition
of complement component 3 (C3) onto bacterial surfaces (Lamb-
ris et al., 2008). On gram-negative bacteria, this can lead to direct
complement-mediated lysis of cells, while gram-positives are
resistant to lysis due to their thick peptidoglycan layer. However,
C3 can also interact with complement receptors on neutrophils
to promote phagocytosis. Deposition of C3 onto pneumococci
can result from activation of either the classical or alternative
pathways (Brouwer et al., 2008). Activation of the classical path-
way can be directed to bacterial surfaces with the aid of anti-
bodies, while the alternative pathway stochastically activates
complement on bacterial surfaces. Once opsonized, bacteria
can be recognized by surface receptors on neutrophils and in-
gested by phagocytosis. Once internalized, S. pneumoniae is
efficiently killed in the phagolysosome (Standish and Weiser,
2009).
Pneumococci resist opsonization by complement due to their
surface capsular polysaccharide (Hyams et al., 2010), which
masks underlying structures and activates complement poorly.
In addition to capsule, the pneumococcus has surface proteins
that directly interact with serum components to evade comple-
ment and subsequent phagocytosis (Dalia et al., 2010; Jarva
et al., 2003). To identify additional factors that promote resis-
tance to thismechanism of killing, we screened a genomic library
for mutants that were more sensitive to OPH killing. A common
phenotype among mutants identified by this screen was an
increase in bacterial chain length (CL). This lead us to hypothe-
size that minimization of CL in S. pneumoniae enhances resis-
tance to OPH killing.
RESULTS
Increased CL Enhances Susceptibility to OPH Killing
A library of pneumococcal mutants was created using the mar-
iner transposon and screened for increased susceptibility to
OPH killing by human neutrophils. In addition to genes affecting
capsular polysaccharide expression, some of the genes identi-
fied by this screen encoded putative cell wall components or
regulatory factors (Table S1 available online). A common pheno-
type among many of these mutants was an increase in bacterial
CL (Figures 1A and 1B). The size of bacterial chains was defined
as their two-dimensional area in phase-contrast images and was
used as a proxy for CL (Figure 1B). Mutant strains from the
screen displayed varying degrees of chain formation, and asevier Inc.
Figure 1. Increased Chain Length Enhances
Susceptibility to Killing by Human Neutrophils
Ex Vivo
(A) Chain formation was assessed among mutant strains
and growth conditions by phase-contrast microscopy
(scale bars represent 10 mm). Details of bacterial strains
and mutants are described in Table S1. Chain formation
was induced in the WT by growth in varying concentra-
tions of choline chloride or in the presence of subinhibitory
concentrations of erythromycin (Erm).
(B) The size of bacterial chainswas calculated from phase-
contrast images and is shown for mutant strains (black
bars), a defined lytA mutant (gray bar), and culture con-
ditions used to induce chain formation in the WT (white
bars). Data are the result of at least 100 chains analyzed
per sample ± standard error of the mean (SEM).
(C) The same bacterial cultures analyzed in (B) were used
in opsonophagocytic (OPH) killing assays where bacteria
were opsonized in a final concentration of 66% baby
rabbit serum, which lacks specific anti-pneumococcal
antibodies, followed by incubation with human neutrophils
(PMNs). Data are from one of two representative experi-
ments performed in duplicate ± range.
(D and E) Linear regressions showing the trend between
size (from B) and percent survival (from C) in OPH assays
for mutant strains (D) and conditions that induce chain
formation in the WT (E). Each data point represents the
mean size and mean percent survival for one strain or
condition tested.
(F) OPH killing assays were performed where WT and lytA
mutant bacteria were mildly sonicated to mechanically
disrupt bacterial chains toward a diplococcal morphology
prior to opsonization in BRS at a final concentration of
66%. Mechanical disruption of chains toward a dip-
lococcal morphology by sonication was confirmed by
analysis of phase-contrast images. Data from unsonicated
samples are from one of two representative experiments
performed in duplicate ± range, and data for sonicated
samples are from one of two representative experiments
and the result of 4 independently sonicated biological
replicates performed in duplicate ± range.
NS, not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001.
See also Figure S1 and Table S1.
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and 1C), and this trendwas highly significant (Figure 1D). A nega-
tive control was the BT1 mutant, which contains the mariner
transposon, but does not display increased chain length and
was not more susceptible to OPH killing (Figures 1B and 1C).
Since chain formation results from the incomplete cleavage of
peptidoglycan between daughter cells after cell division, a posi-
tive control for increased CL was amutant with an in-frame dele-
tion in lytA, which encodes themajor cell wall murein hydrolase in
the pneumococcus (Figures 1B and 1C) (Tomasz, 1968). Growth
of pneumococci in varying concentrations of choline, which
causes release of LytA and other choline binding proteins from
the cell surface, and in subinhibitory concentrations of the bacte-
riostatic antibiotic erythromycin (Erm), also induced chains of
increasing length, providing an independent way to confirm the
effects of CL (Figures 1A and 1C) (Tomasz, 1968). OPH killing
assays performed with the WT grown under these conditions
or with the lytA mutant (Figures 1B and 1C) confirmed that as
CL increased, resistance to OPH killing decreased (Figure 1E).Cell Host &Since some of the genes identified by our screen have putative
roles in peptidoglycan synthesis and modification, it is formally
possible that our mutant strains are more susceptible to OPH
killing due to an altered peptidoglycan structure and not due to
their increased chain length (Table S1). To distinguish between
these possibilities, we performed OPH killing assays where WT
and lytA mutant bacteria were mechanically disrupted toward
a diplococcal morphology. Under these conditions, the lytA
mutant was rendered as resistant to OPH killing as the WT strain
(Figure 1F). As mechanical disruption should not alter the chem-
ical structure of the cell wall in these chains, we attributed the
increased sensitivity of a lytA mutant to its increased size (chain
length). In addition to this phenotypic complementation, we gen-
erated a lytA revertant strain (lytA::pE916), and found that it
chained significantly less than the lytA mutant and was signifi-
cantly more resistant to OPH killing (Figure S1).
Capsular polysaccharide expression is one of the primary
mechanisms the pneumococcus uses to resist complement
deposition and subsequent phagocytic killing. To determineMicrobe 10, 486–496, November 17, 2011 ª2011 Elsevier Inc. 487
Figure 2. Increased Chain Length Enhances Association of Bacteria with Neutrophils and Is Dependent on Complement Activity
(A) For determination of the effect of chain length on neutrophil association, competitive assays were performed between bacterial cultures of the WT and lytA
mutant labeled with either FITC or Cy5. For detection of cell association, samples were examined by flow cytometry, and the percentage of neutrophils with
a positive fluorescent signal (FITC or CY5) was determined. The output ratio of FITC:CY5-labeled PMNs was then normalized to the input ratio of FITC:CY5-
labeled bacteria to calculate a competitive index value (CI). In these assays, a CI of less than 1 indicates that the Cy5-labeled strain is more cell associated than
the FITC-labeled strain, while CI values of greater than 1 indicate that the FITC-labeled strain is more cell associated than the Cy5-labeled strain. The dotted line
indicates a CI of 1—the value expected if strains compete equally well.
(B) Similar experiments were performed where the ratio of bacteria:PMNs was changed from 2:1 to 50:1 and then analyzed by phase-contrast and fluo-
rescence microscopy (the scale bar represents 10 mm). FITC-labeled WT (green) and Cy5-labeled lytAmutant (red) bacteria are distinguished from the punctate
autofluorescence within neutrophils by the size and shape of stained particles.
(C) The importance of complement inOPHkilling of pneumococci was determined byperformance ofOPHkilling assays inwhich bacteriawere opsonized in either
active (BRS) or heat-inactivated (HI BRS) serum (66%). The triangle above columns indicates the trend of chain length among the strains or conditions tested.
All data are from at least two independent experiments performed in duplicate ± SEM. NS, not significant; **, p < 0.01; ***, p < 0.001.
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cytic killing due to decreased expression of capsular polysac-
charide, we performed quantitative capture ELISA assays and
have determined that our mutant strains expressed WT levels
of capsule (data not shown). Thus, differences in capsular poly-
saccharide expression cannot account for the increased sensi-
tivity of mutant strains in our OPH killing assays.
Increased CL Enhances Susceptibility to Uptake
by Human Neutrophils
To determine the mechanism for how CL affects resistance to
OPH killing, we first assessed uptake by human neutrophils by
performing competitive neutrophil association assays. When
the lytA mutant was competed against the WT, it was signifi-
cantly more cell-associated, suggesting that longer chains
were more effectively taken up by host neutrophils (Figure 2A).
Similar results were also obtained when analyzed bymicroscopy
(Figure 2B). Additionally, phagocytosis was likely required for
this effect since cell association was almost completely abro-
gated and the competitive differences lost in reactions where
neutrophils were pre-incubated with cytochalasin D, an inhibitor
of actin polymerization (data not shown). Complement activity in
serum is heat labile, and when strains of increasing CL were
opsonized in heat-inactivated serum, OPH killing was com-
pletely abrogated, indicating that complement was required for
phagocytosis in the context of CL (Figure 2C).
Increased CL Promotes Complement Deposition
on Pneumococci
Since active complement was required for OPH killing, we as-
sessed the impact of CL on complement deposition. Within a488 Cell Host & Microbe 10, 486–496, November 17, 2011 ª2011 Elspopulation of pneumococci, complement deposition is bimodal,
where chains either have C3 bound or do not (Figure 3A) (Brown
et al., 2002). Therefore, we hypothesized that longer chains of
the pneumococcus would be more likely to have complement
bound compared to shorter chains and diplococci. Studying
either the mutant strains or by inducing chain formation in the
WT, increased CL correlated with an increased likelihood of
having C3 bound, and this trend was highly significant (Fig-
ure 3B). When grown in tryptic soy broth, theWT strain produced
chains of varying length, allowing us to examine the effect of CL
on complement deposition within a clonal population. Even
within a WT population, we found that longer chains of pneumo-
cocci were more likely to have C3 deposited on their surface
(Figure 3D). This trend was also observed when human serum
was used as a source of complement to opsonize bacteria (Fig-
ure 3E). Chain formation in theWT is not only evident when pneu-
mococci are grown in tryptic soy broth, but was also observed
when pneumococci were grown in serum, a physiologically
relevant growth medium. Growth of the WT strain in serum in-
duced a small proportion (1%) of the population to form long
bacterial chains (Figure 3A). This phenomenon of long-chain
formation in the WT was also observed when human serum
was used as a growth medium (data not shown). As observed
for long-chain mutant strains, the long chains produced by
growth of the WT in serum were more likely to have C3 bound
compared to shorter chains in the population (Figure 3F).
Once C3 is deposited on a surface, it can spread via the
alternative pathway of complement activation. This has been
observed in the fungal pathogen Cryptococcus neoformans, as
well as on artificial surfaces (Hed et al., 1984; Kozel et al., 1991;
Rosas et al., 2002). To determine whether complement canevier Inc.
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Figure 3. Increased CL Promotes Complement Deposition on Pneumococci
(A–C) Complement deposition onWTpneumococci grown in heat-inactivated baby rabbit serum (HI BRS) was analyzed by immunofluorescencemicroscopywith
a FITC-labeled antibody to C3 (the scale bar represents 10 mm) (A). Open arrows indicate pneumococci that have no complement bound. C3 deposition on
pneumococci was compared among the same mutant strains and growth conditions defined in Figure 1B by immunofluorescence microscopy after pneumo-
cocci were incubated in baby rabbit serum (BRS) at a final concentration of 66%. Data are presented as a linear regression to show the trend between the
percentages of chains positive for C3 and chain length (size) (B). Also shown is a linear regression to analyze the trend between the C3 deposited per chain and
chain length (C). Each data point in this plot represents the mean size and mean C3 deposited per chain for each strain or condition tested, where each data set
was normalized relative to the WT. The slope is indicated on the plot ± SE. Complement deposition was also analyzed within a clonal population of the WT.
(D and E) Bacteria were grown in tryptic soy broth (TS) and opsonized in BRS at a final concentration of 66% (D) or an equivalent concentration of normal human
serum (E).
(F) WT bacteria were also grown in 100% HI BRS followed by opsonization in BRS at a final concentration of 66%.
For quantitative analysis of C3 deposition in (D), (E), and (F), data were binned by size (diplococciz50–100 pixels).
All data are from one of at least two representative experiments and the result of at least 100 chains analyzed per sample ± SEM. ***, p < 0.001.
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deposited per chain and chain length between our mutant strains
and conditions where chain formation was induced in the WT. To
simplify this analysis, both data sets were normalized to the WT
(Figure 3C). If C3 deposition cannot spread from a focus of com-
plement activation, we would expect this trend to have a slope
of 1, indicating that longer chains bind complement proportion-
ately to their increased CL. If C3 deposition can spread from a
focus of complement activation on pneumococci, however, we
would expect this trend to have a slope of > 1, which would
indicate that as CL increased there was a disproportionate
increase in the amountC3 deposited per chain.Whenweperform
this analysis, we find that the slope is significantly > 1 (95% confi-
dence interval: 1.289–2.295), consistent with the hypothesis that
C3 deposition can spread on pneumococci from a focus of
complement activation (Figure 3C). Additionally, when assessing
C3 deposition on pneumococci by immunofluorescence micros-
copy, it is clear that long bacterial chains within the population
are almost fully opsonized by C3, while some diplococci in the
population remain free of complement, which is also consistentCell Host &with the hypothesis that C3 deposition can spread from a focus
of complement activation (Figure 3A).
Together, these data indicate that longer chains of the pneu-
mococcus have an increased likelihood of attaining a focus of
complement activation, which can then deposit and spread C3
throughout the bacterial chain.
DecreasedCL Provides a Competitive Advantage In Vivo
Next, we addressed whether CL affected susceptibility to
complement-dependent clearance in vivo. WT and mutant
strains were competed in a mouse model of systemic infection.
Mutants that displayed increased CL were outcompeted by the
WT, and the magnitude of the effect correlated with the degree
of CL observed in mutant strains (Figure 4). When the WT was
competed against a mutant strain (BT1) that did not display
increased CL, we found that both strains competed equally (Fig-
ure 4). To confirm that the attenuation of mutants with increased
CL in vivo was due to complement-dependent clearance, ani-
mals were depleted of complement activity using cobra venom
factor prior to infection (Van den Berg et al., 1991). Under theseMicrobe 10, 486–496, November 17, 2011 ª2011 Elsevier Inc. 489
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Figure 4. Decreased Chain Length Provides a Competitive Advan-
tage In Vivo
Competition between the indicated mutant and the WT was determined in
a model of systemic infection. Mice were inoculated with pneumococci by
intraperitoneal injection and bacteremia was assessed 16 hr after infection by
quantitative culture of blood. For assessment of the role of complement,
assays were repeated with animals that were depleted of complement activity
by treatment with cobra venom factor (CoVF) (25 mg/animal) 24 hr prior to
inoculation of bacteria. In this assay, CI values of less than one indicate that the
WT outcompeted the mutant, while CI values of greater than one indicate that
the mutant outcompeted theWT. The dotted line indicates a CI of 1—the value
expected if strains compete equally well. The triangle above the graph indi-
cates the trend of chain length among the mutant strains. Comparisons were
made by Mann-Whitney test. NS, not significant; *, p < 0.05; **, p < 0.01.
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(Figure 4). In most cases, mutants competed equally with theWT
in the absence of active complement. Asmutants could compete
equally with theWT, these data indicate that mutant strains were
not attenuated due to an artificial reduction in colony forming
units as a result of chain formation or to other growth defects
in vivo. Thus, increased chain length promoted complement-
dependent clearance during a systemic infection in vivo, consis-
tent with what was observed in OPH killing assays ex vivo.
Agglutination by Antibody Subverts Minimization of Size
as a Complement Evasion Strategy
Antibodies are canonically thought to promote complement
deposition directly via interaction of their Fc domain with com-
plement component C1q to activate the classical pathway of
complement. Growth of S. pneumoniae in serum containing spe-
cific antipneumococcal antibodies has previously been shown
to induce the formation of long bacterial chains, a phenomenon
originally termed the thread reaction (Stryker, 1916). This reac-
tion is seen when bacteria are grown in sera from animals
immunized with a strain of homologous serotype as well as in
sera from patients convalescent from pneumococcal infection
(Stryker, 1916; White et al., 1938). Threading results from the
agglutination of cells during growth as pneumococci divide in a
single plane. During a systemic infection, clearance correlates
with agglutination, although the mechanism for this effect of
antibody has not been defined (Bull, 1915a, 1915b). Similar to
increasedCL, agglutination increases the size of bacterial targets
by amassing them together. We therefore examined the hypoth-
esis that antibodies promote complement-dependent OPH
killing by increasing the size of bacterial targets via agglutination.
To study the effects of agglutination, IgG was purified from
immune rabbit serum generated to a homologous pneumo-490 Cell Host & Microbe 10, 486–496, November 17, 2011 ª2011 Elscoccal serotype. We dissected the role of agglutination in pro-
moting killing of pneumococci by comparing the IgG digestion
products F(ab0)2, which can agglutinate bacteria, and Fab, which
cannot (Figure 5A). Both of these antibody fragments lack Fc, so
they cannot directly activate the classical pathway or interact
with Fc receptors (Figure 5B). IgG and F(ab0)2 both promoted
OPH killing of pneumococci, while Fab did not, demonstrating
that agglutination can promote complement-dependent killing
independent of Fc-effector function (Figure 5C). Additionally,
when bacteria were grown with decreasing concentrations of
F(ab0)2, killing correlated with the degree of agglutination ob-
served (Figure S2). As expected, promotion of OPH killing
by F(ab0)2 required serotype-specific antibody, as antibody
generated to a heterologous serotype did not show this effect
(Figure S2). Complement was necessary for killing by IgG or
F(ab0)2 since opsonization of bacteria in heat-inactivated serum
or preincubation of neutrophils with a blocking antibody to com-
plement receptor 3 (CR3) abrogated killing (Figures 5C and 5D).
Since the effect of IgGwas similar to that of F(ab0)2, this indicated
that Fc receptors on neutrophils did not dramatically enhance
IgG function under these conditions (Figure 5C). Additionally,
OPH killing was still observed when bacteria were opsonized in
MgEGTA buffer, which blocks the classical pathway of comple-
ment, suggesting that the alternative pathway was sufficient to
promote killing in the presence of IgG and F(ab0)2 (Figure 5E).
Importantly, Fab was able to bind pneumococci as well as
IgG and F(ab0)2, indicating that differences in binding affinity
cannot account for the different phenotype observed using
Fab (Figure 5F).
Next, we wanted to determine whether increasing bacterial
size via agglutination promoted OPH killing by increasing the
likelihood that larger bacterial particles would have C3 bound.
Indeed, in the presence of agglutinating concentrations of IgG
or F(ab0)2, the percentage of bacterial particles positive for com-
plement increased, similar to what was observed in the context
of increased CL (Figure 5G and Figures 3A–3F). Additionally,
we observed that C3 deposition on F(ab0)2 agglutinated pneumo-
cocci occurs stochastically over time and appears to spread
from a focus (or few foci) of complement activation, consistent
with what was observed on long bacterial chains (Figure 5I).
Thus, our findings demonstrate that agglutinated bacteria, by
virtue of their increased size, are indirectly more susceptible to
complement deposition due to an increased likelihood of attain-
ing a focus of complement activation that can then spread
throughout the agglutinated mass.
Agglutination may also enhance OPH killing independent of its
ability to alter the dynamics of complement activation. By
amassing bacteria that are pre-opsonized in complement,
agglutination could increase the total C3 present on an opson-
ized target to promote its binding and uptake by phagocytic
cells. To address this possibility, we performed OPH killing
assays where bacteria were preopsonized in serum and then
incubated with IgG, F(ab0)2, or Fab after the complement source
was removed. Under these conditions, we found that IgG and
F(ab0)2 at agglutinating concentrations enhanced killing of pneu-
mococci, while Fab did not (Figure 5H). The density of C3 on indi-
vidual cells is equal in these experiments; however, agglutination
increased the total C3 on a bacterial particle by amassing
these cells together. Thus, agglutination either before or afterevier Inc.
Figure 5. Agglutination Subverts Minimization of Bacterial Size as a Complement Evasion Strategy and Promotes Opsonophagocytic Killing
of a Gram-Positive Pathogen
(A) Effects of agglutination on OPH killing and complement deposition were studied by growing bacteria in the presence of serotype-specific IgG (500 mg/ml)
or equimolar concentrations of F(ab0)2 or Fab. Phase-contrast images of bacteria grown in media alone or supplemented with F(ab0)2 or Fab (scale bars
represent 10 mm).
(B) For confirmation of the absence of Fc, antibody-binding assays were performed on pneumococci with an Fc-specific secondary antibody (GMFI, geometric
mean fluorescence intensity).
(C) OPH killing assays were performed where bacteria were opsonized in BRS (25%) (black bars) or HI BRS (25%) (white bars).
(D) OPH killing assay performed in the presence of 21 mg/106 PMNs of either a blocking antibody to complement receptor 3 (CBRM1/5) or an isotype control
antibody (MOPC21).
(E) OPH killing assay performed in the presence of MgEGTA to block activation of the classical pathway.
(F) For confirmation of equivalent binding between IgG, F(ab0)2, and Fab, antibody-binding assays were performed using a polyclonal secondary antibody to
rabbit F(ab0)2, which recognizes IgG as well as its digestion products.
(G) The percentage of bacterial particles positive for C3 was determined by flow cytometry after bacteria were opsonized in BRS (25%).
(H) OPH killing assay performed where bacteria were preopsonized in BRS (66%) (black bars) or HI BRS (66%) (white bars) followed by agglutination with IgG
(100 mg/ml) or equimolar concentrations of F(ab0)2 or Fab.
(I) C3 deposition on F(ab0 )2 agglutinated cells was analyzed by immunofluorescence microscopy at the time indicated after the addition of 25% BRS (scale bars
represent 10 mm).
All data are the result of at least two independent experiments performed in duplicate ± SEM. *, p < 0.05; ***, p < 0.001. See also Figure S2.
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Figure 6. Agglutination Promotes Complement-Dependent Lysis of a Gram-Negative Pathogen
(A) Haemophilus influenzae was incubated with serotype specific IgG (600 mg/ml) or equimolar concentrations of F(ab0)2 or Fab and analyzed by phase-contrast
microscopy (scale bars represent 10mm).
(B) Serum killing assays performed using the same bacterial cultures analyzed in (A) in which bacteria were incubated in active rabbit serum (33%). Survival is
shown relative to a heat-inactivated serum (HI BRS) control.
(C and D) For confirmation of equivalent binding between IgG, F(ab0)2, and Fab onH. influenzae, antibody-binding assays were performed as in Figure 5F (C), and
for confirmation of the absence of Fc, assays were performed as in Figure 5B (D).
All data are from two independent experiments performed in duplicate ± SEM. *, p < 0.05; **, p < 0.01.
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Minimized Bacterial Size Promotes Virulenceopsonization by complement can promote opsonophagocytic
killing. Preopsonization also confirmed that the interaction
between complement and antibody components does not
need to be direct to promote phagocytosis.
Agglutination by Antibody Promotes Complement-
Dependent Lysis
Since the effect of agglutination on killing pneumococci was
complement dependent, we predicted that it would also pro-
mote killing of a gram-negative pathogen by lysis (i.e., without
phagocytes). To study the effect of agglutination on killing of
Haemophilus influenzae, we purified IgG from serotype-specific
immune serum (type b) and generated the digestion products
F(ab0)2 and Fab. At agglutinating concentrations, F(ab0)2 was
comparable to IgG, and superior to Fab at promoting comple-
ment-dependent lysis (Figures 6A and 6B). Lack of Fc on Fab
and F(ab0)2 was confirmed and binding of Fab to H. influenzae
was at least equal to that of F(ab0)2 and IgG (Figures 6C and
6D). Therefore, in addition to promoting complement-dependent
opsonophagocytosis, antibody also enhanced complement-
mediated lysis that was Fc-independent via agglutination.
DISCUSSION
The complement system is critical for controlling many microbial
infections. As a result, resistance to complement is common
among pathogenicmicrobes. Previously describedmechanisms
to resist complement deposition include the expression of a
surface capsular polysaccharide to mask the microbial surface,
the expression of surface proteins to recruit complement regula-
tory factors and serum proteases, and the secretion of inhibitors
to specifically block complement activation (Lambris et al.,
2008). In this study, we demonstrate that minimization of bacte-
rial size represents a complement evasion strategy that is critical
for resistance to opsonophagocytic killing inS. pneumoniae both
ex vivo and in vivo. In our studies, the effect of bacterial size on
resistance to OPH killing was determined with bacterial chains
that can be successfully ingested even at the maximum size
tested. Within this range, which included natural variants in CL,492 Cell Host & Microbe 10, 486–496, November 17, 2011 ª2011 Elswe found that smaller chains were more resistant to OPH killing.
There has recently been an appreciation for how the cellular
morphology of pathogens affects their virulence (Justice et al.,
2004; Okagaki et al., 2010; Sycuro et al., 2010; Zaragoza et al.,
2010). Our study demonstrates that minimization of pathogen
size can promote virulence. If the size of a pathogen, however,
exceeds the limit for what a phagocyte is able to successfully
ingest, this may also be an effective strategy to evade OPH
killing. This has been demonstrated in recent in vivo studies on
‘‘titan’’ forms of Cryptococcus neoformans and long filamentous
forms of uropathogenic Escherichia coli (Justice et al., 2004;
Okagaki et al., 2010; Zaragoza et al., 2010).
It has long been appreciated that in clinical samples pneumo-
cocci exhibit a diplococcal morphology. In this study, however,
we show that growth of pneumococci in serum, a physiologically
relevant medium, causes a small proportion of the population
(1%) to form long bacterial chains. These long-chain variants
were more susceptible to complement deposition by a mecha-
nism identical to that observed for long-chain mutant strains.
Thus, while the pneumococcus may grow in a long-chain form
in vivo, these chains may be rapidly cleared by opsonophagocy-
tosis, resulting in their absence in clinical samples.
While a small population of bacteria grew as long bac-
terial chains in serum, pneumococci predominantly grew as
diplococci. Among the genus Streptococcus, the growth of
S. pneumoniae as diplococci or short chains is a distinguishing
characteristic. The underlying cause of this difference in bacte-
rial chain length between pneumococci and other streptococci,
however, is unclear. As for traditional studies of bacterial ‘‘viru-
lence factors,’’ we sought to determine the role that diplococcal
morphology had on pneumococcal virulence using mutant
strains and growth conditions that ‘‘knockout’’ this phenotype.
Using these mutants and growth conditions, we have deter-
mined that the diplcoccal morphology of the pneumococcus
is critical for evasion of complement-mediated phagocytic
clearance. As this morphology is critical for the virulence of
S. pneumoniae, it is interesting to speculate that evolutionarily,
resistance to opsonophagocytic clearance was a selective pres-
sure that resulted in the diplococcal morphology of this species.evier Inc.
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mococcus as a complement evasion strategy because other
potentially virulent streptococci may have evolved other mecha-
nisms to evade complement, which resulted in less selective
pressure on the bacterial chain length of those species. Con-
versely, pneumococci may have a greater potential to cause in-
vasive disease compared to other virulent streptococci. Indeed,
the incidence of invasive pneumococcal disease prior to intro-
duction of the pneumococcal conjugate vaccine were at least
20-fold higher than those observed for other virulent strepto-
cocci (CDC, 2008; Davies et al., 1996). While many factors may
govern the incidence rates observed for invasive streptococcal
infections, it is interesting to speculate that decreased bac-
terial chain length in the pneumococcus may be one factor
that promotes the enhanced invasiveness of this streptococcal
species. Moreover, a general characteristic of bacterial patho-
gens that commonly cause invasive infections, such as
Haemophilus influenzae and Neisseria meningitidis, is their
small size.
The positive control for increased pneumococcal chain length
in this study was a defined lytA mutant. This gene encodes the
major lytic murein hydrolase in the pneumococcus and has
previously been implicated in the separation of daughter cells
after cell division (Sanchez-Puelles et al., 1986). LytA is also a
well-characterized virulence factor in the pneumococcus, which
has been shown to play a role during models of pneumonia and
bacteremia (Berry et al., 1989a; Orihuela et al., 2004). LytA is
thought to promote virulence by enhancing the release of pneu-
molysin, an intracellular toxin that is critical for the pathogenesis
of this organism (Berry et al., 1989b; Sanchez-Puelles et al.,
1986). In this study, we show that a lytA mutant had increased
sensitivity to complement-dependent clearance both ex vivo
and in vivo, and have attributed this attenuation to its increased
bacterial chain length. Thus, in addition to its role in pneumolysin
release, LytA activity may be critical in vivo to promote the effi-
cient separation of daughter cells, which allows for evasion of
complement-dependent opsonophagocytic clearance.
We show that increased cell size attenuated the pneumo-
coccus during a systemic infection. However, in the absence of
complement and phagocytes, increasing pathogen size may be
beneficial at distinct sites of infection in vivo. As larger microbes
will likely havemore adhesins as a result of their enlarged surface
area, increasing pathogen size may aid in the establishment of
a mucosal infection, where binding to the epithelium is critical.
As we observed long-chain forms of the pneumococcus when
it was grown in a physiologically relevant medium (serum), we
are interested in determining whether these long-chain variants,
andwhether chain formation in general, is important for pneumo-
coccal infections at mucosal sites (i.e., during the carrier state).
We also addressed how the host may subvert minimization of
size as a virulence strategy via the agglutinating effect of anti-
body. Agglutination of pathogens in vivo is thought to be an
important function of antibodies, although the mechanism for
this effect has not been defined. During a systemic infection, it
has been shown that agglutinating antibodies are more effec-
tive at promoting clearance compared to nonagglutinating anti-
bodies (Margni et al., 1983). Specifically for pneumococci, it
was demonstrated almost 100 years ago that intravenous chal-
lenge of immunized animals resulted in rapid bacterial agglutina-Cell Host &tion (within 30 s), which correlated with clearance, although the
mechanism for this effect was unclear (Bull, 1915a, 1915b).
In this study, we have dissected the role of agglutination in
promoting killing of bacteria by comparing IgG to its digestion
products F(ab0)2 and Fab. We found that F(ab0)2 >> Fab at
promoting complement-dependent opsonophagocytic killing of
S. pneumoniae and lysis of H. influenzae and have attributed
this difference to the ability of F(ab0)2 to agglutinate and, there-
fore, increase the size of bacterial targets. This effect is likely
not specific to these two microbes, since opsonophagocytic
killing of Pseudomonas aeruginosa is also enhanced by F(ab0)2
but not Fab, and importantly, this required the presence of active
complement (Trautmann et al., 1985). Additionally, others have
shown that F(ab0)2 could promote clearance of invasive bacterial
infection while Fab could not, suggesting that agglutination may
play a role independent of Fc-effector function in vivo as well
(Ax et al., 1981).
The literature on activation of the alternative pathway by
F(ab0)2 and Fab fragments is controversial. Some studies show
that both fragments promote alternative pathway-dependent
effects equally, while others show that show that F(ab0)2 is better
than Fab at activating the complement system (Ax et al., 1981;
Ehrnst, 1978; Moore et al., 1982; Trautmann et al., 1985; Winkel-
stein and Shin, 1974). Without Fc, it is unlikely that either mole-
cule directly activates the complement cascade by binding
C1q. F(ab0)2 and Fab, however, can be bound by C3, so they
may promote complement deposition by coating a surface that is
poor at binding complement directly (like capsule) and pro-
viding a substrate for C3 deposition. We have found that
F(ab0)2 >> Fab at promoting complement-dependent effects,
and importantly, these effects correlated with the degree of ag-
glutination observed. Therefore, instead of a difference in the
inherent ability of F(ab0)2 to promote complement dependent
effects over Fab fragments (for which a mechanism remains
unclear), the discrepancy in the literature between the effects
of F(ab0)2 and Fab may be attributed to whether antibody
concentrations used were agglutinating or not. As agglutina-
tion was not examined in these studies it is difficult to conclude
that it accounts for the different phenotypes observed. Based
on this hypothesis, however, one would expect that at sub-
agglutinating concentrations the effect of F(ab0)2 = Fab, while
at agglutinating concentrations the effect of F(ab0)2 >> Fab,
and indeed, our data supports this claim (Figure S2 and Figures
5C and 6B).
IgG was used in this study to examine the effects of agglutina-
tion. The mechanism described here, however, may play a larger
role for immunoglobulins with a higher valency, like polymeric
IgA (four antigen-binding sites) and IgM (ten antigen-binding
sites) due to their enhanced ability to agglutinate antigen. It is
difficult to determine the role that agglutination plays in the func-
tion of these antibodies, since their ability to agglutinate is not
readily separated from their Fc-effector functions.
In summary, we have shown that minimization of bacterial size
allows for complement evasion and have characterized a mech-
anism for how the host may subvert this virulence strategy via
agglutinating antibody. Since complement is critical for the
clearance of many pathogenic microbes, this study has broad
implications for how pathogen size and morphology can affect
virulence.Microbe 10, 486–496, November 17, 2011 ª2011 Elsevier Inc. 493
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Bacterial Strains and Culture Conditions
Bacterial strains (Table S1) were grown as previously described (Dalia et al.,
2010; Gould and Weiser, 2002). When appropriate, media was supplemented
with streptomycin (Str, 100 mg/ml), spectinomycin (Spec, 200 mg/ml), or eryth-
romycin (Erm, 1 mg/ml).
Mariner mutants of TIGR4 were generated exactly as previously described
(Hava and Camilli, 2002). The M1 and lytA revertant strains were also gener-
ated in this study. For details please refer to the Supplemental Experimental
Procedures.
Complement Sources
Three- to four-week baby rabbit serum (BRS) was aliquoted and frozen
at 80C until use (Pel-Freez Biologicals). Normal human serum (NHS)
was isolated from human whole blood as previously described (Dalia et al.,
2010).
Opsonophagocytic Killing Assays
OPH killing assays were performed exactly as previously described (Dalia
et al., 2010). In brief, 103 PBS-washed late log-phase bacteria (in 10 ml) were
preopsonized by addition of 20 ml 100% BRS (unless otherwise indicated)
for 30 min at 37C, followed by the addition of 105 PMNs (40 ml) in +++ buffer
(130 ml), which were isolated from human whole blood as previously described
(Dalia et al., 2010). Reactions were then incubated at 37C for 45min with rota-
tion. Reactions were then stopped by placing on ice and viable counts of
bacteria were determined by dilution plating. Percent survival was determined
relative to control reactions where no PMNs were added. Thus, for mutants
with increasing chain formation, an artificial reduction in CFUs due to growth
of mutant strains as chains during the duration of the experiment did not alter
percent survival data since data were normalized to control reactions where an
equal amount of growth should have occurred.
When specified, OPH killing assays were modified. For determination of the
role of complement, reactions were performedwhere bacteria were opsonized
in HI BRS. For determination of the role of the alternative pathway on OPH
killing, bacteria were opsonized in gelatin veronal buffer containing MgEGTA
to block the classical pathway of complement activation (Boston Bioproducts).
Where indicated, PMNs were preincubated with 20 mM cytochalasin D, to
inhibit actin polymerization (block phagocytosis), or a vector control (DMSO)
(Sigma Aldrich). For determination of the role of complement receptor 3
(CR3) on OPH killing, neutrophils were pretreated with 21mg / 106 neutrophils
of a blocking antibody (CBRM1/5) or an isotype control antibody (MOPC21) at
37C for 30 min with rotation (Biolegend) prior to use in OPH killing assays.
Where indicated, bacterial cultures at an OD620 of 0.5 were mildly sonicated
for 3 s with a 40TL probe (Ultra Sonic Power).
For data when percent survival or C3 deposition is related to the size of
bacterial chains, samples for microscopy were prepared from the same
cultures used in OPH killing assays. The degree of chain formation observed
between mutant strains and growth conditions where chain formation was in-
duced in the WT was variable from day to day. Therefore, chain length (size)
was determined for each experiment independently when correlating chain
length with percent survival in OPH killing assays or the amount of C3 depos-
ited in complement deposition assays.
For additional details about control experiments please refer to the
Supplemental Experimental Procedures.
Serum Bactericidal Killing Assays
Bactericidal killing assays were performed as previously described (Nakamura
et al., 2011). In brief, 105mid-log-phase bacteria (OD620 = 0.3–0.4) were diluted
into +++ buffer (70 ml), and then added to 140 ml active BRS (50% in +++ buffer)
or 140 ml heat-inactivated BRS (50% in +++ buffer) for 45min at 37Cwith rota-
tion. Assays were stopped by placing reactions on ice, and dilutions were
made for quantitative culture. Killing in BRS was determined relative to reac-
tions where bacteria were incubated in heat-inactivated BRS.
Microscopy
Samples (8 ml) were prepared for microscopy on agarose pads (1% in PBS) as
previously described (Batchelor and Goulian, 2006).494 Cell Host & Microbe 10, 486–496, November 17, 2011 ª2011 ElsSamples were analyzed on an Olympus IX81 microscope with a 1003
phase-contrast objective (Olympus UPLFLN). Fluorescence microscopy was
performed with a 100 W halogen bulb and Chroma filter cubes 41017 and
41043. Images were taken using an Andor IXON+ 887 camera. For fluores-
cence microscopy, separate images were taken using each filter set as well
as a phase-contrast image.
All images were analyzed with Image J. The size (in pixels) of bacterial chains
is defined as their two-dimensional area based on the ‘‘Auto Threshold’’ func-
tion, which defined the outline of chains. Shapes that were not chains and
chains on the border of images were manually excluded from subsequent
analysis.
Cell Association Assays
Neutrophil cell association assays were performed essentially as previously
described (Dalia et al., 2010). Bacteria were labeled with fluorescein isothio-
cyanate (FITC, 0.2 mg/ml) or Cy5 (2 pmol/ml). For competitive assays strains
were mixed 1:1 and 43 105 bacteria/mix were opsonized in baby rabbit serum
(66%), followed by incubation with 23 105 neutrophils. By flow cytometry, the
proportion of FITC:Cy5 positive bacteria in the inocula is defined as the input
ratio, while the proportion of FITC:Cy5 positive neutrophils is defined as the
output ratio.
Competitive index ðCIÞ=

output ratio
input ratio

Complement Deposition Assays
C3 deposition assays were performed as previously described (Dalia et al.,
2010). In brief, 106 late-log-phase bacteria were incubated in 100 ml 66%
BRS or 66% NHS (diluted in +++) for 30 min at 37C. Bacteria were then
washed and resuspended in –+ buffer containing 5% fetal calf serum. C3
binding was then detected by incubation of bacteria in 100 ml 1:100 dilution
of a FITC-conjugated anti-rabbit C3 or anti-human C3 antibody as appropriate
(MP Biomedical). Control reactions included bacteria that were opsonized in
heat-inactivated serum, as well as reactions where bacteria were incubated
in buffer alone.
For analysis by microscopy, the size and outline of cells was determined
from the phase-contrast image with Auto Threshold. With the fluorescence
image, the Integrated Density (IntDen) (defined as the sum of the values of
the pixels in the image or selection) was determined within the outline of
each chain as defined by the phase-contrast image. Reactions where bacteria
were opsonized in heat-inactivated BRS or NHS were used to define the
background fluorescence. The IntDen of chains from these reactions was
divided by their size (in pixels) to define the ‘‘background intensity per pixel.’’
For experimental samples:
C3
chain
= ðIntDen ðAUÞÞ 

Background intensity
pixel ðAUÞ

3 ðSize ðpixelsÞÞ

:
The percent of cells positive for complement (percent C3 positive) was
determined by first analyzing a histogram of C3/chain data from a given exper-
iment to determine a threshold value above which cells were scored as posi-
tive for C3. The proportion of cells that scored positive for complement was
also analyzed by flow cytometry as previously described (Dalia et al., 2010).
Mouse Model
Six- to eight-week-old C57BL/6 mice were inoculated intraperitoneally with
2 3 106 CFU of a 1:1 mixture of mutant and WT bacteria. The proportion of
mutant and WT bacteria was determined by plating on both selective (using
appropriate antibiotics—supports growth of mutant) and nonselective
(supports growth of mutant and WT) media. The input ratio was defined by
the inocula and the output ratio was defined by quantitative culture of blood,
and the CI was calculated as in cell association assays. Animals that cleared
the infection were excluded from subsequent analysis since a CI could not
be calculated for these animals.
Cleavage of IgG
Rabbit serum generated to pneumococcal serotypes 4 and 23 was provided
by Robert Austrian. Rabbit serum to Haemophilus influenzae type b was
commercially available (Becton, Dickinson, and Company). IgG was purifiedevier Inc.
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and cleaved with F(ab0)2 and Fab cleavage kits according to manufacturers’
instructions (Thermo Scientific).
Antibody Binding Assays
Antibody binding experiments were performed as previously described
(Dalia et al., 2010). In brief, 106 bacteria were incubated with IgG (50 mg/ml)
or equimolar concentrations of F(ab0)2 or Fab. Binding was determined
with a goat anti-rabbit secondary antibody as specified (1:4000) (Jackson
ImmunoResearch). Binding was detected with a FITC-conjugated anti-goat
IgG (1:100) and analyzed by flow cytometry.
Statistical Analysis
Comparisons were made by two-tailed Student’s t test unless otherwise
specified.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and one table and can be found with this article online at
doi:10.1016/j.chom.2011.09.009.
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